{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:10:42Z","timestamp":1787317842051,"version":"build-2736575974"},"update-to":[{"DOI":"10.1016\/j.ekir.2020.12.018","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000}}],"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:00:00Z","timestamp":1608163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006591","name":"FibroGen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006591","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ekir.2020.12.018","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T17:46:44Z","timestamp":1608832004000},"page":"613-623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["RETRACTED: Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis"],"prefix":"10.1016","volume":"6","author":[{"given":"Robert","family":"Provenzano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Fishbane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Szczech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil G.","family":"Saikali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyson T.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Houser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Frison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin J.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kin-Hung","family":"Peony Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Neff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2020.12.018_bib1","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/ki.2011.368","article-title":"The contribution of chronic kidney disease to the global burden of major noncommunicable diseases","volume":"80","author":"Couser","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.12.018_bib2","series-title":"Chapter 1. Incidence, prevalence, patient characteristics, and treatment modalities","year":"2018"},{"key":"10.1016\/j.ekir.2020.12.018_bib3","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0272-6386(12)70359-1","article-title":"Mortality rates among dialysis patients in Medicare's End-Stage Renal Disease Program","volume":"15","author":"Eggers","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.12.018_bib4","series-title":"Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","year":"2007"},{"key":"10.1016\/j.ekir.2020.12.018_bib5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ki.2014.15","article-title":"Early mortality in patients starting dialysis appears to go unregistered","volume":"86","author":"Foley","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.12.018_bib6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2020.12.018_bib7","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A\u00a0trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2020.12.018_bib8","doi-asserted-by":"crossref","first-page":"2085\u20122098","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2020.12.018_bib9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ki.2008.295","article-title":"Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes","volume":"74","author":"Szczech","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.12.018_bib10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0272-6386(04)01086-8","article-title":"Epoetin requirements predict mortality in hemodialysis patients","volume":"44","author":"Zhang","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.12.018_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol Cell"},{"key":"10.1016\/j.ekir.2020.12.018_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/CIR.0000000000000156","volume":"132","author":"Hicks","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2020.12.018_bib13","series-title":"Guidance for Industry on Diabetes Mellitus---Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes; Availability","year":"2008"},{"key":"10.1016\/j.ekir.2020.12.018_bib14","unstructured":"US Food and Drug Administration. FDA briefing document for the Oncologic Drugs Advisory Committee (ODAC). December 7, 2011. Available at https:\/\/wayback.archive-it.org\/7993\/20170403224026\/https:\/\/www.fda.gov\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/OncologicDrugsAdvisoryCommittee\/ucm235829.htm. Accessed February 18, 2021."},{"key":"10.1016\/j.ekir.2020.12.018_bib15","series-title":"Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","year":"2014"},{"key":"10.1016\/j.ekir.2020.12.018_bib16","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1681\/ASN.2007111181","article-title":"The effect of altitude on dosing and response to erythropoietin in ESRD","volume":"19","author":"Brookhart","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.12.018_bib17","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/ndt\/gfr681","article-title":"Altitude and the risk of cardiovascular events in incident US dialysis patients","volume":"27","author":"Winkelmayer","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2020.12.018_bib18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jama.2009.84","article-title":"Altitude and all-cause mortality in incident dialysis patients","volume":"301","author":"Winkelmayer","year":"2009","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.1016\/j.ekir.2022.01.1069","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"record-id":"36210"},{"DOI":"10.1016\/j.ekir.2021.01.035","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000}},{"DOI":"10.1016\/j.ekir.2020.12.018","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000}},{"DOI":"10.1016\/j.ekir.2022.01.1069","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000}}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024920318519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024920318519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:34:51Z","timestamp":1762832091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024920318519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2468024920318519"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2020.12.018","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2020.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}